{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:53:45Z","timestamp":1791114825464,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Enid"},{"name":"Arthur Home Memorial Scholarship"},{"name":"University of Western Australia Scholarship for International Research Fees (SIRF)"},{"name":"Neuromuscular Foundation of Western Australia"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jneuroim.2012.04.007","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T21:39:08Z","timestamp":1335908348000},"page":"66-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): A population control study"],"prefix":"10.1016","volume":"249","author":[{"given":"Arada","family":"Rojana-udomsart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Castley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mastaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.04.007_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08916930701619219","article-title":"Autoantibodies in celiac disease","volume":"41","author":"Alaedini","year":"2008","journal-title":"Autoimmunity"},{"issue":"Pt 10","key":"10.1016\/j.jneuroim.2012.04.007_bb0010","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/brain\/123.10.2030","article-title":"Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies","volume":"123","author":"Amemiya","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0020","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.1780390910","article-title":"Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0025","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","article-title":"Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis","volume":"63","author":"Badrising","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0035","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar1862","article-title":"In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype","volume":"8","author":"Chinoy","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis\u2014diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.21452","article-title":"Interplay between inflammation and degeneration: using inclusion body myositis to study \u201cneuroinflammation\u201d","volume":"64","author":"Dalakas","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ana.410410116","article-title":"Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations","volume":"41","author":"Dalakas","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0055","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1373\/clinchem.2004.047233","article-title":"Use of low concentrations of human IgA anti-tissue transglutaminase to rule out selective IgA deficiency in patients with suspected celiac disease","volume":"51","author":"Fernandez","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.1994.tb06604.x","article-title":"HLA associations with inclusion body myositis","volume":"98","author":"Garlepp","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0190","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/BOR.0b013e32834b53cc","article-title":"Inclusion body myositis","volume":"23","author":"Greenberg","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/s10165-008-0028-1","article-title":"Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period","volume":"18","author":"Hayashi","year":"2008","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/PL00007850","article-title":"Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies","volume":"249","author":"Hengstman","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0080","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1093\/brain\/awr258","article-title":"Update on sporadic inclusion body myositis","volume":"134","author":"Hohlfeld","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","article-title":"Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis","volume":"21","author":"Koffman","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0090","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00415-003-0204-3","article-title":"Analysis of HLA class I and II alleles in sporadic inclusion-body myositis","volume":"250","author":"Lampe","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0175","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00296-010-1637-5","article-title":"A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis","volume":"32","author":"Limaye","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0105","first-page":"66","article-title":"Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC","volume":"28","author":"Mastaglia","year":"2009","journal-title":"Acta Myol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0110","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","article-title":"Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria","volume":"28","author":"Mastaglia","year":"2002","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0120","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mus.20766","article-title":"Genetics of inclusion-body myositis","volume":"35","author":"Needham","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0115","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/jnnp.2007.138891","article-title":"Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases","volume":"79","author":"Needham","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians","volume":"84","author":"O'Hanlon","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies","volume":"85","author":"O'Hanlon","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1749-6632.2009.04810.x","article-title":"Autoantibody screen in inflammatory myopathies high prevalence of antibodies to gliadin","volume":"1173","author":"Orbach","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0180","series-title":"Autoantibodies","author":"Peter","year":"1996"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0150","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/1529-0131(199804)41:4<710::AID-ART19>3.0.CO;2-K","article-title":"Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy","volume":"41","author":"Rider","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0155","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/brain\/awn053","article-title":"Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2011.02.011","article-title":"Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex","volume":"235","author":"Scott","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0170","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":"Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy","volume":"55","author":"Selva-O'Callaghan","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/mus.20652","article-title":"Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy","volume":"35","author":"Selva-O'Callaghan","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2012.04.007_bb0185","series-title":"The Busselton Study: Mapping Population Health Cardiovascular and Respiratory Disease Risk Factors in Busselton, Australia 1998","author":"Welborn","year":"1998"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:20:05Z","timestamp":1759047605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812001221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0165572812001221"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.04.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): A population control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}